Drug Approval | September 06, 2024
Strides receive USFDA approval for Theophylline ER tablets, 300 mg and 450 mg
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
The revenue for the Q1FY25 came in at Rs 1,085.7 crore, up 16.6 per cent YoY
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
Arco Lab now holds a 50% stake in Neviton
The product has been in-licensed from Strides and will be commercialized by Amneal
Subscribe To Our Newsletter & Stay Updated
